is a distinctive feature of Plasmodium falciparum malaria and is a central event in the development of life-threatening complications such as cerebral malaria. PRBCs adhere to several EC-expressed molecules in vitro, but the relative importance of these interactions in vivo remains unclear. Chondroitin sulfate A (CSA) is the most recent EC surface-associated molecule to be implicated in the adhesive process. Accordingly, we have studied adhesion of PRBCs to CSA in vitro using a parallel-plate flow chamber. Under controlled flow conditions, PRBCs adhered to CSA in a concentration-dependent manner at wall-shear stresses up to 0.2 Pa, a value that is within the physiological URING INFECTION WITH Plasmodium falciparum, D parasitized red blood cells (PRBCs) adhere to endothelial cells (ECs) and accumulate in the microvasculature of various organs. This phenomenon, which is known as sequestration,'.' is complex at the cellular level because of the potential involvement of a number of EC-expressed adhesion molecules including intercellular adhesion molecule-1 (ICAM-l), CD36, thrombospondin (TSP), vascular cell adhesion molecule-1 (VCAM-l), and E-selectin.' Recently, chondroitin sulfate A (CSA), a glycosaminoglycan associated with the EC surface, has also been added to this list.?' Studies to identify the molecules to which PRBCs can adhere have been performed exclusively using cultured cells or purified proteins in highly artificial assays under conditions that ignore the shear forces exerted by flowing blood.
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A good way to identify those receptors, or combination of receptors, that actually operate in vivo is by the use of in vitro flow systems that can accurately mimic the hemodynamic forces that act on PRBCs in the circulation.' Once shear forces are operative, it becomes apparent that different receptors mediate quantitatively and qualitatively different forms of adhesion. For example, we have previously shown that, when adhesion was tested at shear stresses typical of those for postcapillary venules, PRBCs that adhered to CD36 or TSP remained stationary, whereas those adhering to We set out to examine the interaction of PRBCs with the most recent receptor to be implicated in sequestration, CSA, using a flow-based assay. Our studies infer that CSA expressed on ECs in vivo could itself immobilize flowing PRBCs and/or facilitate the interaction of PRBCs with other receptors and may, therefore, contribute to the pathogenesis of falciparum malaria.
MATERIALS AND METHODS

Malaria Parasites
A recently derived line of P falciparum, FAF-EA8 CH054 (originally from the Brazilian Ituxi isolate, It) was cultured in human Group 0 RBCs in vitro as previously described but with the addition of 200 pmol/L hypoxanthine to the culture medium.x Cultures were kept synchronous and were frequently enriched for PRBCs expressing knobs as previously described?"' FAF-EA8-CHO5 was panned twice on immobilized CSA using the procedure described by Ockenhouse et al" to create a parasite line (designated CS2) that adhered well to CSA. CS2 was expanded in culture, and multiple aliquots were cryopreserved and stored in liquid nitrogen for subsequent experiments.
Immobilization of CSA CSA was covalently linked to dipalmitoylphosphatidylethanolamine (PE) as previously described4 to facilitate immobilization on plastic. The concentration of CSA-PE conjugate in the resulting solution was approximately 1 mg/mL when measured by hexuronic acid assay. Spatially discrete drops (5 pL) of CSA-PE solution were spotted onto rectangular plastic slides and incorporated into the base of a parallel-plate flow chamber as previously described.*
Adhesion Assay
Adhesion of PRBCs to CSA was visualized and quantified in a parallel-plate flow chamber sited on the stage of an inverted phasecontrast light microscope as described Briefly, cryopreserved aliquots of CS2 were thawed and cultured in vitro for 20 hours to allow the parasites to mature to the trophozoite stage. Parasitemia was assessed by examination of Giemsa-stained smears and averaged 0.5% rings, 5.1% trophozoites, and 0.1% schizonts. ] for 17 aliquots of PRBCs used). The lower internal surface of the flow channel was viewed directly using a 40X water-immersion objective lens while PRBCs were flowed through the chamber. Two basic protocols modified from those previously described by Nash et all2 were followed.
PRBCs were allowed to flow through the chamber for 5 to 10 minutes at a wall-shear stress between 0.05 Pa and 0. 4 Pa, followed by cell-free adhesion medium at the same stress for 5 minutes to wash away nonadherent cells. While flow was maintained, adherent PRBCs were counted in a number of precalibrated microscopic fields of view (each of area 0.17 mm2) and were expressed as adherent PRBCs/mm2/107 PRBCs perfused. In some experiments, adherent cells were then detached by a brief period of flow (= 5 seconds) at high ( FJ 18 Pa) shear stress before another sample of PRBCs was flowed through the chamber.
PRBCs were allowed to flow through the chamber at 0.05 Pa for 5 to 10 minutes, the nonadherent cells were washed away, and then adherent PRBCs/mm2 were quantified as above. Adherent PRBCs were then exposed to stepwise increases in shear stress up to 2.5 Pa, each of 5 minutes in duration, and the number of PRBCs remaining adherent were counted at each level of stress.
Adhesion of PRBCs from frow.
Removal of adherent PRBCs by Jow.
Inhibition and Reversal of Adhesion
The ability of CSA or the structurally related glycosaminoglycan, heparan sulfate (HS), to prevent adhesion of flowing PRBCs was tested by quantifying adhesion at 0.05 Pa in the presence or absence of CSA or HS. RBCs were suspended in adhesion medium either with or without the appropriate glycosaminoglycan and were incubated at room temperature for 10 minutes before being introduced into the flow chamber. The ability of soluble CSA to reverse already established adhesion was assessed by flowing adhesion medium containing CSA (10 or 50 pg/mL) for 1 hour at a shear stress of either 0.05 Pa or 0.1 Pa over PRBCs that had previously been allowed to adhere at the same stress.
All assays were performed at room temperature (20°C to 22°C) and pH 1.4, except for three experiments in which adhesion at pH 7.4 and pH 6.8 was compared.
RESULTS
Specificity and Nature of Adhesion
Adherent PRBCs were confined to circular areas (-3 mm diameter) of the plastic slide to which CSA-PE had been immobilized. Over 99% of adherent cells contained mature pigmented parasites. Direct observation of the adhesive surface during the period over which the cell suspension was flowing through the chamber showed that PRBCs generally became instantaneously immobilized. A small number of PRBCs were rolling continuously over, but in close contact with, the immobilized CSA. At the time when adhesion was quantified, the majority (>99%) of adherent PRBCs were stationary, irrespective of the level of wall-shear stress or concentration of adsorbed CSA-PE, although both of these parameters had a dramatic effect on the absolute level of adhesion (see below).
Assays were performed to determine the coating concentrations of CSA-PE that gave maximal levels of adhesion at wall-shear stresses of 0.05 Pa and 0.1 Pa. At both stresses, there was an increase in the number of adherent PRBCs with increasing CSA-PE concentration to 100 pg/mL. However, increasing the concentration of CSA-PE to 1,OOO pUglmL caused no further increase in the level of adhesion. At all concentrations of CSA-PE tested, all adherent PRBCs were stationary when adhesion was quantified. Subsequent experiments were performed using CSA-PE at a concentration of 100 pg/mL unless otherwise stated.
In two experiments, a heparin-PE conjugate, prepared in the same manner as CSA-PE and adsorbed onto the slide at a concentration of 260 pg/mL, did not support adhesion of PRBCs, indicating that adhesion was mediated entirely by the CSA moiety of the CSA-PE conjugate. Furthermore, in two separate experiments at 0.05 Pa, treatment of a CSA-PE-coated plastic slide with chondroitinase ABC for 30 minutes at room temperature completely prevented adhesion of flowing PRBCs. In contrast, incubation with heparitinase under the same conditions had no inhibitory effect (3,073 ? 233 and 3,109 ? 247 adherent PRBCs/mm2/107 PRBCs before and after treatment with heparitinase respectively; mean +-SD for two separate experiments).
Adhesion of PRBCs to CSA was not affected by changes in pH. In three paired experiments, there was no significant 
Adhesion of PRBCs to CSA From Flow
To determine the effect of wall-shear stress on adhesion, PRBCs were allowed to flow through the CSA-PE-coated chamber at increasing levels of wall-shear stress over a range of 0.05 to 0.4 Pa (Fig 1A) . The number of adherent PRBCs was greatest at 0.05 Pa but decreased markedly with increasing wall-shear stress so that at 0.1 Pa and 0.2 Pa adhesion was only 27% and 5% of its value at 0.05 Pa, respectively. At 0.4 Pa, PRBCs did not adhere.
Detachment of PRBCs from CSA by Increasing Flow
The effect of stepwise increases in the level of wall-shear stress on PRBCs that had adhered to CSA at 0.05 Pa was determined (Fig 1B) . The number of adherent PRBCs progressively decreased with increasing wall-shear stresses up to 2.5 Pa. A measure of the strength of the interaction (750) was inferred from the stress required to remove 50% of adherent PRBCs (determined by extrapolation from the "wash-off" curves)12 and averaged 1.2 +-0.2 Pa (mean 2 SD for three separate experiments).
Direct observation of adherent PRBCs showed that, as the level of stress was increased to 1.0 Pa, some PRBCs detached spontaneously, whereas those remaining adherent showed an increasing degree of shear-induced deformation. When the stress was increased to 1.5 Pa and above, PRBCs continued to detach spontaneously, but an increasing proportion of those remaining adherent began to roll slowly but remained in close contact with the adhesive surface, until they reached the edge of the spot of immobilized CSA and were washed away with the flow. 4000 """"; T 
Inhibition and Reversal of Adhesion
The effect of soluble CSA in the flowing PRBC suspension on adhesion of PRBCs was first investigated under conditions that had been established for the maximum level of adhesion, ie, 0.05 Pa and 100 pg/mL CSA-PE (Table 1) . Soluble CSA inhibited adhesion of PRBCs in a concentration-dependent manner over the range of 1 to 250 pg/mL, with greater than 80% of adhesion being inhibited at the highest concentration of CSA tested. If the concentration of CSA-PE adsorbed on the slide was reduced, adhesion was much more effectively inhibited at lower concentrations of CSA. For example, CSA at 50 pg/mL almost totally (>99%) ablated adhesion to CSA-PE adsorbed at 40 pg/mL. In contrast, the same concentration of CSA inhibited adhesion to CSA-PE adsorbed at 100 pg/mL by only 67.7%. The presence of HS (50 pg/mL) in the flowing cell suspension had little inhibitory effect on adhesion (Table 1) . Flowing adhesion medium containing CSA (10 or 50 pg/ mL) for 1 hour at a shear stress of either 0.05 Pa or 0.1 Pa through the chamber failed to consistently reverse already established adhesion. In four separate experiments, the number of PRBCs remaining adherent after flow of CSA for 1 hour averaged 99.6% of the number adherent before exposure to CSA ( Table 2) . Additionally, in one separate experiment, CSA (10 pg/mL) also failed to reverse adhesion of PRBCs adhering to a lower concentration (40 pg/mL) of adsorbed CSA-PE (the number of adherent PRBCs after flow of CSA at 0.05 Pa for 1 hour = 95.0% of the initial number adherent). For
DISCUSSION
Our studies suggest that CSA could play a significant role in sequestration in vivo. PRBCs adhered to CSA at wallshear stresses within the physiological range proposed for venules in v~v o , '~. '~ and, once adhered, PRBCs were able to resist detachment, even when exposed to supravenular stresses. It is possible that adherent PRBCs may be exposed to such flow patterns in larger diameter vessels and in circulatory spaces (sinusoids) in which PRBCs frequently sequester in vivo, such as in the pla~enta'~.'~ and the sinusoids of the bone where flow is complex. CSA is presented on the surface of cells attached to a protein backbone forming a proteoglycan. The most likely CSA-containing proteoglycan associated with the EC surface is thrombomodulin (TM), an abundant anticoagulant molecule that may have one or two CSA chains attached to TM is expressed on ECs in the brain" and on syncytiotrophoblasts of the placenta," two organs in which a disproportionately large number of PRBCs sequester. The difference in the level of expression and degree of glycosylation of TM on ECs from different anatomical sites is not well understood, but such differences have been detected between neonatal umbilical vein and adult arterial ECs, for example. Comparison of adhesion of PRBCs to CSA with adhesion to other known receptors shows that it most closely resembles adhesion to CD36, in that it is a stationary interaction with similar characteristics of adhesion from flow' and subsequent detachment by flow. For CD36, Cooke et al' previously quantified adhesion of PRBCs from flow but did not perform "wash-off'' (disruption of adhesion) experiments. However, our unpublished observations do suggest that "wash-off' curves for PRBCs adhering to CSA or CD36 are similar. Comparison of the interaction of PRBCs with CSA to that of the interaction with ICAM-1 is more problematic because the latter interaction is a continuously rolling one and, hence, difficult to quantify; therefore, comparisons to assess the relative "strength" of the interaction may not be valid. However, the interaction of PRBCs with the surface of nonactivated human umbilical vein ECs (presumably via ICAM-1) can be converted from a rolling interaction into a stationary one if the ECs are first fixed with glutaraldehyde." Using such a model, Nash et all' estimated the shear stress required to detach 50% of adherent PRBCs from the fixed ECs (750) as a measure of the "strength" of the adhesive interaction. The 750 for PRBCs adhering to glutaraldehydefixed human umbilical vein ECs was reported to be in the range of 0.6 to 0.8 Pa, approximately 50% lower than the 750 measured here for interaction with CSA. Although the molecular nature of the interaction between PRBCs and the fixed ECs was not elucidated, it was most likely via ICAM-1, because human umbilical vein ECs do not express CD3625 and nonactivated ECs are not likely to express VCAM-1 and E-selecthZ6
The ability of any compound to reverse established adhesion has never been shown under conditions of flow in vitro. Our studies have demonstrated the utility of CSA in preventing adhesion, but, unlike previous findings using a static assay: we could not show reversal of preestablished adhesion. This observation, taken together with our findings that flowing PRBCs become instantaneously immobilized from flow and form predominantly stationary interactions, is consistent with a hypothesis that the interaction between the PRBC-expressed adhesion receptor and CSA has a rapid onrate but a slow off-rate. The discrepant results in the different assays may relate to the inherent differences in the fluid dynamics of the two assay systems. It may be that a subset of PRBCs exist that adhere with low affinity to CSA. Such cells may have insufficient density of PRBC-expressed receptor to permit firm immobilization under flow conditions but may bind in static assays in which inhibitory shear dynamic forces are absent while adhesion is occumng. Soluble CSA can compete with these low-affinity binding PRBCs, thus giving the appearance of reversal of adhesion in static assays only. This could be tested experimentally if the fraction of reversibly bound PRBCs from a static assay were recovered and tested for their ability to adhere in the flow chamber.
We believe that flow-based assays are a useful prelude to clinical testing of therapeutics that interfere with adhesion of PRBCs to the vascular endothelium. Concentrations of chondroitin sulfate achievable in human plasma by oral deliveryz7 are significantly higher than those required to inhibit or reverse adhesion in vitro. Thus, CSA (or lower molecular weight fractions of CSA) could act as a useful pharmaceutical to prevent a subset of PRBCs from sequestering in vivo. Whether such an intervention alone would have a useful therapeutic effect is unknown, but it is worthy of further investigation.
